Infant Formula Reformulation Drives Structured Lipid Demand
UK infant formula manufacturers are increasingly specifying structured lipids positioned around palmitic acid distribution matching human milk fat profiles, since documented structural positioning allows manufacturers to make defensible nutritional claims that conventional interesterified fats cannot support at comparable pricing. This demand has grown fastest among premium infant nutrition brands, where structural lipid positioning directly affects product differentiation and parental purchasing decisions. Several major suppliers have expanded dedicated structured lipid production capacity specifically to serve this growing demand, recognizing that once a manufacturer qualifies a structured lipid supplier, switching costs remain meaningful given the reformulation validation work involved.
Market Impact: Adds 3 percent baseline demand stab








